Treatment Modification After Initiating Second-Line Medication for Type 2 Diabetes

Among adults with type 2 diabetes who started noninsulin second-line therapy, most modified treatment within 1 year. Discontinuation was by far the most common modification.

Related Keywords

Quebec ,Canada ,Lake Shore ,California ,United States ,Chicago ,Illinois ,Northwestern University ,Eli Lilly ,Endocr Disord ,Sanya Pasricha ,National Health ,Adm ,Value Health ,American Diabetes Association Scientific Sessions On ,Health Aff Millwood ,Northwestern University Feinberg School Of Medicine ,American College Of Physicians ,Nutrition Examination ,Study Research Group ,Institute For Public Health ,Unitedhealth Group ,Division Of Endocrinology ,Novo Nordisk ,Program Collaborative Group ,Health Serv Res ,Institute Inc ,Medicare Advantage ,Appendix Figure ,Diabetes Complications Severity Index ,Appendix Table ,Sterling Harris ,American Diabetes Association Scientific Sessions ,General Internal Medicine ,Public Health ,Molecular Medicine ,Northwestern University Feinberg School ,Applied Research ,Diabetes Res ,Clinical Guidelines Committee ,American College ,Ann Intern ,Complications Severity Index ,Metab Syndr ,Manag Care Spec ,Gen Intern ,Diabetes Study ,Northern California ,Health Serv ,Diabetes ,T2d ,Modification ,